Summit X’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Summit X's IBB Position: Q4 2018 in Review
Summit X sold out of iShares Biotechnology ETF (IBB) in Q4 2018, closing a stake of 21,944 shares — an estimated $2.67M sold.
Summit X first reported a position in IBB in Q2 2017 and held it in 6 quarters. The position peaked at $3.08M in Q3 2017. 649 funds tracked by Wall St. Rank hold IBB as of Q4 2018.
- Summit X reported no remaining iShares Biotechnology ETF position as of Q4 2018 after selling out during the quarter.
- Summit X sold 21,944 iShares Biotechnology ETF shares in Q4 2018, an estimated $2.67M.
- Summit X first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 6 quarters.
- Summit X's iShares Biotechnology ETF position peaked at $3.08M in Q3 2017.
- 649 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2018.
Based on Summit X's 13F filing for Q4 2018, filed 13 Feb 2019.